000 01698 a2200493 4500
005 20250516105410.0
264 0 _c20130307
008 201303s 0 0 eng d
022 _a1873-5894
024 7 _a10.1016/j.mri.2012.06.009
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aKurland, Brenda F
245 0 0 _aPromise and pitfalls of quantitative imaging in oncology clinical trials.
_h[electronic resource]
260 _bMagnetic resonance imaging
_cNov 2012
300 _a1301-12 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Review
650 0 4 _aApoptosis
650 0 4 _aBiomarkers
_xmetabolism
650 0 4 _aCell Differentiation
650 0 4 _aClinical Trials as Topic
650 0 4 _aDiagnostic Imaging
_xmethods
650 0 4 _aDrug Delivery Systems
650 0 4 _aHumans
650 0 4 _aMagnetic Resonance Imaging
_xmethods
650 0 4 _aMedical Oncology
_xmethods
650 0 4 _aNeoplasms
_xdiagnosis
650 0 4 _aPositron-Emission Tomography
_xmethods
650 0 4 _aSignal Transduction
650 0 4 _aTomography, X-Ray Computed
_xmethods
700 1 _aGerstner, Elizabeth R
700 1 _aMountz, James M
700 1 _aSchwartz, Lawrence H
700 1 _aRyan, Christopher W
700 1 _aGraham, Michael M
700 1 _aBuatti, John M
700 1 _aFennessy, Fiona M
700 1 _aEikman, Edward A
700 1 _aKumar, Virendra
700 1 _aForster, Kenneth M
700 1 _aWahl, Richard L
700 1 _aLieberman, Frank S
773 0 _tMagnetic resonance imaging
_gvol. 30
_gno. 9
_gp. 1301-12
856 4 0 _uhttps://doi.org/10.1016/j.mri.2012.06.009
_zAvailable from publisher's website
999 _c22030318
_d22030318